3rd Quarter - Report

FABIANI & COMPANY for TETRAPHASE PHARMACEUTICALS

Period 3rd Quarter 2009 Filed Oct 15, 2009 Signed by Gary Martin, CFO

Official filing
Firm
FABIANI & COMPANY
Client
TETRAPHASE PHARMACEUTICALS
Income
$20,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Tetracycline / antibiotic use for bio-defense

LobbyistCovered position, as disclosed
MELISSA DUPREE —
WENDY SHELTON —

Contacted: SENATE; Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES

Health Issues HCR

Tetracycline / antibiotic use for bio-defense

LobbyistCovered position, as disclosed
MELISSA DUPREE —
WENDY SHELTON —

Contacted: Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; SENATE

Veterans VET

Tetracycline / antibiotic use for bio-defense

LobbyistCovered position, as disclosed
MELISSA DUPREE —
WENDY SHELTON —

Contacted: HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.